Back to search

Article

Fleming: An AI Agent for Antibiotic Design for Mycobacterium tuberculosis

2025-04-07

Abstract excerpt

Antibiotic development is challenged by high costs and failure rates. Artificial intelligence (AI) holds promise to overcome these challenges by predicting inhibitory properties of novel compounds, generating new candidates, and contextualizing property predictions in the biological background. Fleming is an integrative AI agent that explores novel chemical space to identify lead compounds meeting multiple criteri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32ffc02b-394c-5762-83df-380c6802e02e
DOI
10.1101/2025.04.01.646719
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fleming: An AI Agent for Antibiotic Design for Mycobacterium tuberculosisDOI 10.1101/2025.04.01.646719
Modification-aware AI enables terminal chemical modifications for peptide design and discovers potent antimicrobialsSemantic proximity
Generative AI, molecular docking and molecular dynamics simulations assisted identification of novel transcriptional repressor EthR inhibitors to target Mycobacterium tuberculosisSemantic proximity
A generative artificial intelligence approach for antibiotic optimizationSemantic proximity
Generative AI-assisted Virtual Screening Pipeline for Generalizable and Efficient Drug RepurposingSemantic proximity
De Novo Design and Bioactivity Prediction of SARS-CoV-2 Main Protease Inhibitors Using ULMFitSemantic proximity
Target-aware Molecule Generation for Drug Design Using a Chemical Language Model <sup>*</sup>Semantic proximity
Unlocking the Future of Drug Development: Generative AI, Digital Twins, and BeyondSemantic proximity
Generative Drug Design in a Loop with dtSFMSemantic proximity
Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity
De-novo generation of novel phenotypically active molecules for Chagas disease from biological signatures using AI-driven generative chemistrySemantic proximity
AIPAMPDS: an AI platform for antimicrobial peptide design and screeningSemantic proximity
TumFlow: An AI Model for Predicting New Anticancer MoleculesSemantic proximity
Select a neighboring publication to make it the new centre.